Stock Price Movement and Market Context
On 2 Mar 2026, Poly Medicure Ltd’s shares opened with a gap down of -3.61%, reflecting immediate pressure from market participants. Despite an intraday recovery that saw the stock reach a high of Rs.1303 (up 2.89%), it ultimately closed near its low at Rs.1210.35, down 4.43% from the previous close. This new 52-week low contrasts sharply with the stock’s 52-week high of Rs.2936.70, underscoring the extent of the decline over the past year.
The stock has experienced a modest rebound over the last two days, gaining 2.21% cumulatively, yet it remains below its 20-day, 50-day, 100-day, and 200-day moving averages, indicating sustained downward momentum. It is currently trading above its 5-day moving average, suggesting some short-term support, but the longer-term trend remains subdued.
In comparison, the Medical Equipment/Supplies/Accessories sector has gained 2.15% today, while the broader Sensex index, after a sharp gap down of 2,743.46 points, recovered by 1,474.51 points to trade at 80,018.24, still down 1.56% on the day. The Sensex remains below its 50-day moving average, though the 50DMA is above the 200DMA, signalling mixed market conditions.
Financial Performance and Valuation Concerns
Poly Medicure Ltd’s financial indicators reveal a challenging environment. The company reported a quarterly Profit After Tax (PAT) of Rs.75.86 crores for the December 2025 quarter, reflecting an 11.0% decline compared to the previous period. Operating profit margins have also contracted, with the operating profit to net sales ratio falling to a low of 22.52% in the same quarter.
Additionally, the company’s debtors turnover ratio for the half-year period stands at 4.02 times, the lowest in recent years, indicating slower collection cycles which may impact liquidity. Despite these pressures, the company maintains a low average debt-to-equity ratio of zero, suggesting a conservative capital structure with limited leverage.
Return on Equity (ROE) is reported at 12.4%, which, when combined with a Price to Book Value ratio of 4.4, points to a relatively expensive valuation. The stock trades at a discount compared to its peers’ historical averages, yet this valuation premium may be a factor in the subdued market sentiment.
From struggle to strength! This Small Cap from Textile - Machinery is showing early turnaround signals that look promising. Position yourself now for explosive growth potential ahead!
- - Early turnaround signals
- - Explosive growth potential
- - Textile - Machinery recovery play
Long-Term and Sectoral Performance
Over the past year, Poly Medicure Ltd’s stock has declined by 37.45%, significantly underperforming the Sensex, which has risen by 9.32% during the same period. The company’s profits, however, have increased by 11.9% over the last year, indicating some operational resilience despite the stock’s poor price performance. The PEG ratio stands at 3.1, suggesting that the stock’s price appreciation has not kept pace with earnings growth.
In the longer term, the company’s operating profit has grown at an annualised rate of 17.77% over the last five years, which is modest relative to sector peers. The stock has also underperformed the BSE500 index over the last three years, one year, and three months, reflecting persistent challenges in delivering superior returns.
Poly Medicure Ltd holds a significant position within its sector, with a market capitalisation of Rs.12,822 crores, making it the second largest company in Healthcare Services behind Lenskart Solutions. It accounts for 10.88% of the sector’s market capitalisation and contributes 16.54% of the industry’s annual sales, which total Rs.1,781.58 crores.
Institutional Holdings and Market Sentiment
The company has a relatively high institutional holding of 23.24%, indicating that a substantial portion of its shares is held by investors with greater analytical resources. This level of institutional ownership often reflects confidence in the company’s fundamentals, although it has not translated into positive price momentum in recent months.
Despite the recent two-day gain of 2.21%, the stock’s overall trajectory remains subdued, with the current Mojo Score at 30.0 and a Mojo Grade of Sell, upgraded from a previous Strong Sell on 11 Feb 2026. The market cap grade is 3, reflecting the company’s mid-tier size within its sector.
Poly Medicure Ltd or something better? Our SwitchER feature analyzes this small-cap Healthcare Services stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Summary of Key Metrics
To summarise, Poly Medicure Ltd’s recent stock performance reflects a combination of subdued earnings growth, valuation concerns, and sectoral pressures. The stock’s 52-week low of Rs.1210.35 is a notable milestone, highlighting the challenges faced by the company in maintaining investor confidence despite its sizeable market presence and steady sales contribution within the Healthcare Services sector.
While the company’s low debt levels and institutional backing provide some stability, the decline in profitability ratios and slower receivables turnover remain areas of concern. The stock’s relative underperformance against benchmarks such as the Sensex and BSE500 further emphasises the need for cautious analysis of its financial health and market positioning.
Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →
